ATE411052T1 - Gonadotropin releasing hormone analoga konjugate mit steroid hormonen - Google Patents
Gonadotropin releasing hormone analoga konjugate mit steroid hormonenInfo
- Publication number
- ATE411052T1 ATE411052T1 AT04725716T AT04725716T ATE411052T1 AT E411052 T1 ATE411052 T1 AT E411052T1 AT 04725716 T AT04725716 T AT 04725716T AT 04725716 T AT04725716 T AT 04725716T AT E411052 T1 ATE411052 T1 AT E411052T1
- Authority
- AT
- Austria
- Prior art keywords
- hormones
- gonadotropin releasing
- hormone
- steroid
- conjugates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0307777.3A GB0307777D0 (en) | 2003-04-04 | 2003-04-04 | Conjugate compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE411052T1 true ATE411052T1 (de) | 2008-10-15 |
Family
ID=9956164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04725716T ATE411052T1 (de) | 2003-04-04 | 2004-04-05 | Gonadotropin releasing hormone analoga konjugate mit steroid hormonen |
Country Status (8)
Country | Link |
---|---|
US (1) | US7700559B2 (de) |
EP (1) | EP1613357B1 (de) |
JP (1) | JP4614943B2 (de) |
AT (1) | ATE411052T1 (de) |
DE (1) | DE602004017151D1 (de) |
ES (1) | ES2318284T3 (de) |
GB (1) | GB0307777D0 (de) |
WO (1) | WO2004087215A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602005020359D1 (de) | 2005-01-14 | 2010-05-12 | Camurus Ab | Topische bioadhäsive formulierungen |
US9649382B2 (en) | 2005-01-14 | 2017-05-16 | Camurus Ab | Topical bioadhesive formulations |
CA2594710C (en) * | 2005-01-14 | 2011-01-25 | Camurus Ab | Topical bioadhesive formulations |
DE602005026998D1 (de) | 2005-01-14 | 2011-04-28 | Camurus Ab | Somatostatin-analog-formulierungen |
KR101245022B1 (ko) | 2005-01-21 | 2013-03-19 | 카무러스 에이비 | 약제학적 지질 조성물 |
US8546326B2 (en) | 2005-06-06 | 2013-10-01 | Camurus Ab | Glp-1 analogue formulations |
EP2129402A2 (de) * | 2007-02-16 | 2009-12-09 | KTB Tumorforschungsgesellschaft mbH | Prodrug mit rezeptor- und antigen-target |
US20080261933A1 (en) * | 2007-04-23 | 2008-10-23 | Jens Hoffmann | Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases |
GB0711656D0 (en) | 2007-06-15 | 2007-07-25 | Camurus Ab | Formulations |
GB0716385D0 (en) | 2007-08-22 | 2007-10-03 | Camurus Ab | Formulations |
ES2633453T3 (es) | 2008-01-24 | 2017-09-21 | Esperance Pharmaceuticals | Constructos de fusión de dominios líticos y métodos de preparación y utilización de los mismos |
GB0815435D0 (en) | 2008-08-22 | 2008-10-01 | Camurus Ab | Formulations |
US8828938B2 (en) * | 2009-04-24 | 2014-09-09 | Polypeptide Laboratories A/S | Method for the manufacture of degarelix |
US10093961B2 (en) | 2009-12-22 | 2018-10-09 | Esperance Pharmaceuticals | Methods for diagnosis of and predicting treatment efficacy of hormone receptor expressing tumors, cancers and neoplasias |
US20150272622A1 (en) | 2011-12-22 | 2015-10-01 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
US9216037B2 (en) | 2013-06-21 | 2015-12-22 | Previvo Genetics, Llc | Uterine lavage for embryo retrieval |
US11672843B2 (en) | 2012-05-25 | 2023-06-13 | Camurus Ab | Somatostatin receptor agonist formulations |
JP6559066B2 (ja) | 2012-10-30 | 2019-08-14 | エスペランス ファーマシューティカルズ, インコーポレイテッド | 抗体/薬剤結合体及び使用方法 |
EP4223298A3 (de) | 2013-03-15 | 2023-08-16 | AbbVie Inc. | Zusammensetzungen zur verwendung bei der behandlung von schweren menstruationsblutungen |
EP3275888B1 (de) * | 2016-07-28 | 2019-09-25 | Council of Scientific & Industrial Research | Hybrid aus progesteron und kationischem lipid als antikrebsmittel und verfahren zur synthese davon |
JP7184775B2 (ja) | 2016-12-14 | 2022-12-06 | パーデュー・リサーチ・ファウンデイション | 黄体化ホルモン放出ホルモン受容体(lhrh-r)コンジュゲートおよびその使用 |
JP2021531236A (ja) | 2018-04-19 | 2021-11-18 | アッヴィ・インコーポレイテッド | 重度の月経出血を治療する方法 |
CN113166086A (zh) * | 2018-09-05 | 2021-07-23 | 组装生物科学股份有限公司 | 用于治疗hbv的环状磺酰胺化合物 |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3974135A (en) | 1971-06-24 | 1976-08-10 | Karl Folkers | Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for producing the same |
US3953416A (en) | 1971-12-20 | 1976-04-27 | Karl Folkers | Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for manufacturing the same |
US3843065A (en) | 1972-10-13 | 1974-10-22 | Bauer Bros Co | Labyrinth seal ring for pulp refiner |
US3849389A (en) | 1972-10-19 | 1974-11-19 | Lilly Co Eli | Intermediates to the 5-phe analog of lh-rh |
US3813382A (en) | 1972-12-20 | 1974-05-28 | American Home Prod | Analogs of luteinizing hormone releasing factor substituted in position 9 |
US3890437A (en) | 1973-10-03 | 1975-06-17 | American Home Prod | Method of inhibiting fertility in mammals using D{13 Phe{hu 2{b {13 D{13 Ala{hu 6{b {13 LRF |
US3855199A (en) | 1973-10-03 | 1974-12-17 | American Home Prod | P-glu-d-phe-t rp-ser-tyr-d-ala-leu-arg-pro-gly-nh2-and intermediates |
US3914412A (en) | 1973-10-11 | 1975-10-21 | Abbott Lab | {8 Des{13 Gly{9 {0 10 -Gn{13 RH nonapeptide amide analogs in position 6 having ovulation-inducing activity |
US4072668A (en) | 1973-11-06 | 1978-02-07 | The Salk Institute For Biological Studies | LH-RH Analogs |
US3892723A (en) | 1974-02-04 | 1975-07-01 | American Home Prod | P-Glu-Trp-Ser-Tyr-D-Pgl-Leu-Arg-Pro-Gly-NH{HD 2 {B and intermediates |
US3901872A (en) | 1974-03-13 | 1975-08-26 | American Home Prod | P-glu-his-trp-ser-tyr-d-pgl-leu-arg-pro-gly-nh' 2 'and intermediates |
US3886135A (en) | 1974-04-10 | 1975-05-27 | American Home Prod | P-GLU-D-PHE-TRP-SER-TYR-D-PGL-LEU-ARG-PRO-GLY-NH{HD 2 {B and intermediates |
US3896104A (en) | 1974-05-22 | 1975-07-22 | American Home Prod | P-glu-his-trp-ser-tyr-d-lys-leu-arg-pro-gly-nh' 2 'and intermediates |
US3915947A (en) | 1974-07-11 | 1975-10-28 | Lilly Co Eli | Des-{8 His{hu 2{b ,Gly{hu 10{b {9 -D-Ala{hu 6 {b LHRH ethylamide as an inhibitor of LHRH |
DE2438350C3 (de) | 1974-08-09 | 1979-06-13 | Hoechst Ag, 6000 Frankfurt | Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen |
US3937695A (en) | 1974-11-04 | 1976-02-10 | American Home Products Corporation | P-Glu-Trp-Ser-Tyr-D-Lys-Leu-Arg-Pro-Gly-NH2 and intermediates |
US3929759A (en) | 1974-11-04 | 1975-12-30 | American Home Prod | P-Glu-D-Phe-Trp-Ser-Tyr-D-Arg-Leu-Arg-Pro-Gly-NH{HD 2 {B and intermediates |
US4010125A (en) | 1975-06-12 | 1977-03-01 | Schally Andrew Victor | [D-Trp6 ]-LH-RH and intermediates therefor |
FR2329293A1 (fr) | 1975-10-29 | 1977-05-27 | Parke Davis & Co | Nouveaux nonapeptides et procedes pour leur production |
US4018914A (en) | 1975-11-13 | 1977-04-19 | Abbott Laboratories | Parturition inducement |
US4022761A (en) | 1976-01-19 | 1977-05-10 | Parke, Davis & Company | Tripeptides and methods for their production |
US4022759A (en) | 1976-01-19 | 1977-05-10 | Parke, Davis & Company | Tripeptides and methods for their production |
US4022760A (en) | 1976-01-19 | 1977-05-10 | Parke, Davis & Company | Tripeptides and methods for their production |
US4034082A (en) | 1976-03-01 | 1977-07-05 | Abbott Laboratories | Method to prevent reproduction in warm-blooded female animals with nonapeptides |
US4075189A (en) | 1976-09-15 | 1978-02-21 | Parke, Davis & Company | Hexapeptides |
US4101538A (en) | 1977-06-13 | 1978-07-18 | Warner-Lambert | Nonapeptides and methods for their production |
US4124577A (en) | 1977-06-13 | 1978-11-07 | Warner-Lambert | Nonapeptides and methods for their production |
US4075192A (en) | 1977-06-13 | 1978-02-21 | Parke, Davis & Company | Nonapeptides and methods for their production |
US4143133A (en) | 1977-10-03 | 1979-03-06 | American Home Products Corporation | Claudogenic-interceptive nonapeptides |
US4124578A (en) | 1978-01-03 | 1978-11-07 | American Home Products Corporation | Antiovulatory polypeptides |
US4234571A (en) | 1979-06-11 | 1980-11-18 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone |
US4253997A (en) | 1979-12-17 | 1981-03-03 | American Home Products Corporation | Anti-ovulatory decapeptides |
US4292313A (en) | 1980-04-15 | 1981-09-29 | The Salk Institute For Biological Studies | LRF Antagonists |
US4341767A (en) | 1980-10-06 | 1982-07-27 | Syntex Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists |
AU9102582A (en) | 1981-12-10 | 1983-06-16 | David Howard Coy | Lh-rh antagonists |
US4504414A (en) | 1983-03-28 | 1985-03-12 | Board Of Regents, The University Of Texas System | Synthetic pyridyl-alanyl decapeptides having antiovulatory activity |
US4677193A (en) | 1985-02-22 | 1987-06-30 | The Salk Institute For Biological Studies | Peptides containing an aliphatic-aromatic ketone side chain |
US4705778A (en) | 1985-10-22 | 1987-11-10 | Sri International | Orally active LHRH analogs |
WO1990009799A1 (en) * | 1989-02-23 | 1990-09-07 | Colorado State University Research Foundation | GnRH ANALOGS FOR DESTROYING GONADOTROPHS |
US6156731A (en) | 1989-05-10 | 2000-12-05 | G. D. Searle & Co. | Polypeptide composition for oral administration |
US5064939A (en) | 1990-02-06 | 1991-11-12 | The Salk Institute For Biological Studies | Cyclic gnrh antagonists |
AU647138B2 (en) | 1990-03-16 | 1994-03-17 | Laboratoires Serono Sa | Treatment of polycystic ovarian disease |
CA2112566A1 (en) | 1991-07-01 | 1993-02-18 | Graham J. Moore | Non-desensitizing analogs of gnrh and other biologically active ligands |
US5371070A (en) | 1992-11-09 | 1994-12-06 | The Salk Institute For Biological Studies | Bicyclic GnRH antagonists and a method for regulating the secretion of gonadotropins |
SG50426A1 (en) | 1993-05-20 | 1998-07-20 | Biotech Australia Pty Ltd | Lhrh antagonists |
US5413990A (en) | 1993-08-06 | 1995-05-09 | Tap Pharmaceuticals Inc. | N-terminus modified analogs of LHRH |
US5502035A (en) | 1993-08-06 | 1996-03-26 | Tap Holdings Inc. | N-terminus modified analogs of LHRH |
EP0738154A1 (de) | 1993-08-06 | 1996-10-23 | Abbott Laboratories | N-terminus modifizierte lhrh analoge |
TW449600B (en) | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
CA2163325A1 (en) | 1994-11-21 | 1996-05-22 | Kaneyoshi Kato | Amine compounds, their production and use |
UY23948A1 (es) | 1995-02-08 | 2001-10-25 | Takeda Chemical Industries Ltd | Derivados de anillos condensados de tiofeno su producción y uso. |
KR0134534B1 (ko) * | 1995-03-20 | 1998-04-21 | 김은영 | (-)3(s)-메틸벤즈옥사진 유도체의 제조방법 |
GB2310660A (en) | 1996-03-01 | 1997-09-03 | Merck & Co Inc | Benzoxazinone oxytocin receptor antagonists |
US5756497A (en) | 1996-03-01 | 1998-05-26 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
ID17260A (id) | 1996-04-26 | 1997-12-11 | Takeda Chemical Industries Ltd | Turunan tieno piridina dan produksi serta gunanya |
AU706818B2 (en) | 1996-05-20 | 1999-06-24 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
JP2000511186A (ja) | 1996-05-20 | 2000-08-29 | メルク エンド カンパニー インコーポレーテッド | ゴナドトロピン放出ホルモン拮抗薬 |
WO1997044339A1 (en) | 1996-05-20 | 1997-11-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6500934B1 (en) | 1996-07-24 | 2002-12-31 | Michael Rush Lerner | Bivalent agonists for G-protein coupled receptors |
EP0882736A1 (de) | 1997-06-02 | 1998-12-09 | Laboratoire Theramex S.A. | Peptidanaloge des LH-RH, ihre Verwendungen und die sie enthaltenden pharmazeutischen Zusammensetzungen |
JP2001520997A (ja) | 1997-10-28 | 2001-11-06 | メルク エンド カムパニー インコーポレーテッド | 性腺刺激ホルモン放出ホルモン拮抗薬 |
US6211224B1 (en) * | 1997-10-28 | 2001-04-03 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
WO1999033831A1 (en) | 1997-12-26 | 1999-07-08 | Takeda Chemical Industries, Ltd. | Nitrogen-containing heterocyclic compounds, their production and use |
CA2317451A1 (en) | 1998-02-11 | 1999-08-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
WO1999041252A1 (en) | 1998-02-11 | 1999-08-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
NZ506839A (en) | 1998-03-09 | 2003-05-30 | Zealand Pharma As | Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
AU4393199A (en) | 1998-06-26 | 2000-01-17 | Takeda Chemical Industries Ltd. | Thienopyridine compounds, their production and use |
US6191115B1 (en) | 1998-08-12 | 2001-02-20 | Abbott Laboratories | C-terminus modified heptapeptide LHRH analogs |
WO2000053178A1 (en) | 1999-03-10 | 2000-09-14 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
TWI225863B (en) | 1999-03-24 | 2005-01-01 | Takeda Chemical Industries Ltd | Thienopyrimidine compounds, their production and use |
AU2001248760A1 (en) | 2000-04-13 | 2001-10-30 | Takeda Chemical Industries Ltd. | Preventives/remedies for alzheimer's disease |
CA2415010C (en) | 2000-07-05 | 2011-05-03 | Yamanouchi Pharmaceutical Co., Ltd. | Propane-1,3-dione derivatives useful as gnrh receptor antagonist |
JP2003137814A (ja) | 2001-08-10 | 2003-05-14 | Takeda Chem Ind Ltd | GnRHアゴニストの併用剤 |
FR2849380A1 (fr) | 2002-12-27 | 2004-07-02 | Ernest Loumaye | NOUVELLE UTILISATION D'UN AGONISTE DU GnRH |
-
2003
- 2003-04-04 GB GBGB0307777.3A patent/GB0307777D0/en not_active Ceased
-
2004
- 2004-04-05 EP EP04725716A patent/EP1613357B1/de not_active Expired - Lifetime
- 2004-04-05 US US10/552,110 patent/US7700559B2/en not_active Expired - Fee Related
- 2004-04-05 ES ES04725716T patent/ES2318284T3/es not_active Expired - Lifetime
- 2004-04-05 JP JP2006506091A patent/JP4614943B2/ja not_active Expired - Fee Related
- 2004-04-05 DE DE602004017151T patent/DE602004017151D1/de not_active Expired - Lifetime
- 2004-04-05 AT AT04725716T patent/ATE411052T1/de not_active IP Right Cessation
- 2004-04-05 WO PCT/GB2004/001478 patent/WO2004087215A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20060247177A1 (en) | 2006-11-02 |
GB0307777D0 (en) | 2003-05-07 |
WO2004087215A1 (en) | 2004-10-14 |
JP4614943B2 (ja) | 2011-01-19 |
DE602004017151D1 (en) | 2008-11-27 |
ES2318284T3 (es) | 2009-05-01 |
EP1613357A1 (de) | 2006-01-11 |
JP2006522085A (ja) | 2006-09-28 |
EP1613357B1 (de) | 2008-10-15 |
US7700559B2 (en) | 2010-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE411052T1 (de) | Gonadotropin releasing hormone analoga konjugate mit steroid hormonen | |
UY27793A1 (es) | Pirazolopiridinas substituidas con carbamato | |
WO2006009734A8 (en) | Gonadotropin releasing hormone receptor antagonists | |
WO2006033700A3 (en) | Her2 antibody composition | |
AR053651A1 (es) | Tratamiento combinado de anticuerpo antictla4 r inhibidor de aromatasa para el cancer de mama | |
CY1116520T1 (el) | Φαρμακοτεχνικη μορφη fulvestrant | |
WO2006058012A3 (en) | Gonadotropin releasing hormone receptor antagonists | |
CR6654A (es) | Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco | |
DE602004028651D1 (de) | Neutralisierbares epitop von hgf und an dieses bindende neutralisierender antikörper | |
WO2005084296A3 (en) | Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogernase 3 | |
CR20120384A (es) | Composición de farmaco conjugado | |
SV2008002612A (es) | Forma de dosificacion de liberacion retardada oral altamente biodisponibles de succionado de o-desmetilvanlafaxina ref. am101721salvo | |
HRP20050173A2 (en) | Composition containing an androgenous 11?-halogensteroid and a progestational hormone, and male contraceptive based on said comosition | |
CR10459A (es) | Derivados de leptomicina | |
ECSP055574A (es) | Uso de derivados de tio-oxindol en el tratamiento de condiciones relacionadas con hormonas. | |
AU2002364954A1 (en) | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO BLyS | |
CY1114121T1 (el) | Λυοφιλοποιημενα σκευασματα fsh/lh | |
WO2007062483A8 (en) | Increasing pregnancy rates | |
AU2003255820A8 (en) | Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer | |
DK1526856T3 (da) | Farmaceutisk sammensætning omfattende estetrolderivater til anvendelse i cancerterapi | |
DE60223542D1 (de) | Zusammensetzung mit fulvestrant | |
GT200500121A (es) | Derivados de sulfamoilbenzoato y sulfamoilaminobenzoato de estradiol. | |
TW200612962A (en) | Estriol and estetrol prodrugs | |
WO2005011617A3 (en) | Transmucosal dosage forms for brain-targeted steroid chemical delivery systems | |
AU2003267551A1 (en) | Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |